NCT00950248: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT00950248 |
|---|---|
| Title | Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 1, 2009 |
| Completion date | April 30, 2018 |
| Required reporting date | April 30, 2019, midnight |
| Actual reporting date | Nov. 15, 2018 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |